SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Incyte (INCY)
INCY 104.52+0.4%9:35 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: lwd who wrote (1306)1/10/2000 9:52:00 AM
From: lwd  Read Replies (2) of 3202
 
Monday January 10, 8:08 am Eastern Time
Company Press Release
SOURCE: Intraware, Inc.
Incyte Pharmaceuticals Selects Intraware to Streamline Their Web-Based Software Selection
Intraware Compariscope Service Offers Incyte Pharmaceuticals Objective Technical Analysis - Increasing Speed and Effectiveness
ORINDA, Calif., Jan. 10 /PRNewswire/ -- Intraware, Inc. (Nasdaq: ITRA - news) the leading IT e-Marketplace for Web-based software and services, today announced that Incyte Pharmaceuticals, Inc. (Nasdaq: INCY - news), a leading genomics information company, has selected the Intraware Compariscope software evaluation service to provide objective product evaluations to aid in the selection process of the company's strategic application software purchases. Using the Intraware Compariscope service, Incyte Pharmaceuticals was able to efficiently derive a customized list of potential Web application servers and make a choice based on objective information provided by Compariscope.

``The Intraware Compariscope service has saved me over 24 hours of time,' said Mark Stobbs, Incyte's Senior WebMaster. ``My previous software product evaluation process was very time consuming and consisted of reading trade journals, doing research online, and basically running my own clipping service. With Compariscope, I have an objective, standardized, one-stop solution comparison site that I can rely on to help analyze and determine the best products to purchase specifically for Incyte's needs.'

Incyte plans to continue utilizing Intraware's resources. ``Right now, we're in the process of using Compariscope to determine two more product purchases,' said Stobbs. ``We also plan to use Intraware's Ask James(SM) Advice Service to address some of the questions about the two new product categories we're exploring. I would highly recommend Intraware's services to any IT professional in need of an objective resource to streamline the evaluation and purchase of their Web-based business software.'

``As of today, Intraware has over 6,300 customers and we offer each of them a competitive advantage by offering a one-stop solution to efficiently and cost-effectively research, evaluate, purchase, download, and update business-class software online,' said Cindy Mascheroni, vice president of customer services at Intraware. ``Providing unique technology services and personalized functionality gives our customers more control over technology decisions and decreases their workload -- and that's fundamental to our business.'

About Intraware Compariscope

Compariscope is an interactive service that delivers objective, Web-based software analysis tailored to each customer's corporate requirements including a complete technical analysis, pertinent reviews, white papers, research articles and executive summaries on a wide range of software market segments and products. The Compariscope service categorizes Internet software products, defines evaluation criteria, conducts extensive product testing and evaluation, and presents customized findings to IT users over the Web.

About Incyte Pharmaceuticals, Inc.

Incyte Pharmaceuticals, Inc. is a leading provider of an integrated platform of genomic technologies designed to aid in the understanding of the molecular basis of disease. Incyte develops and markets genomic databases, genomic data management software, microarray-based gene expression services, related reagents and services. These products and services assist pharmaceutical and biotechnology researchers with all phases of drug discovery and development including gene discovery, understanding disease pathways, identifying new disease targets and the discovery and correlation of gene sequence variation to disease.

About Intraware

Intraware, Inc. (Nasdaq: ITRA - news) is the leading IT e-Marketplace for Web-based software and services. The company enables IT professionals worldwide to efficiently and cost-effectively research, evaluate, purchase, download, and update business-class software online. As a business-to-business e-commerce company, Intraware provides software through its premier online purchasing service, intraware.shop, comprehensive IT information and interactive research services through the Intraware IT Knowledge Center, and software update management services through Intraware SubscribNet.

Intraware's unique spectrum of innovative Internet-based services has attracted strategic relationships with industry-leading vendors including Allaire Corporation, Bluestone Software, Inc., Computer Associates International, Inc., CommerceOne, Inc., Hewlett-Packard Company, Informix Corporation, Infoseek, Interwoven, Inc., Macromedia, Inc., Novell, Inc., PeopleSoft, Inc., Sun-Netscape Alliance, Sybase, Inc. and Vignette Corporation. Intraware is a publicly-held company with headquarters located at 25 Orinda Way, Orinda, California 94563; (925) 253-4500; FAX (925) 253-4599; intraware.com.

For more information contact: Carole Sinclair of Intraware, Inc., 925-253-6707, carole@intraware.com; or Fiona Hughes of Dave & Bairey Communications, 925-672-9547, fiona@dbcomm.com, for Intraware, Inc.

The statements in this news release referring to Incyte Pharmaceuticals' plans to continue using Intraware products and services are forward-looking statements that may involve a number of risk factors and uncertainties. Factors that could cause actual results to differ materially from those anticipated in this news release include the absence of a binding legal agreement by Incyte Pharmaceuticals to purchase Intraware products or services. Further information on potential factors that could affect Intraware's financial results is included in Intraware's Form 10-K for the 1999 fiscal year and Form 10-Q for the quarter ended August 31, 1999 filed with the Securities and Exchange Commission (SEC). For further information, please refer to Intraware's SEC filings, copies of which are available from Intraware without charge or online at intraware.com.

Intraware, Compariscope, and SubscribNet, are registered trademarks or service marks, and NetInsights, IT Knowledge Center, Radarscope, and intraware.shop are among the trademarks and service marks, of Intraware, Inc. All other company names, product names, service marks and trademarks mentioned herein are trademarks of their respective owners.

SOURCE: Intraware, Inc.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext